528 material Form 8-K filings that 462 companies we cover made with the SEC in January 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Sonos said on January 13, 2025 that it is eliminating the Chief Product Officer role, effective immediately, and informed Maxime Bouvat-Merlin of the change. He will stay on as an advisor to the Interim Chief Executive Officer for a mutually agreed transition period. The filing gives no financial figures, and the company describes the change as an elimination of the role rather than a stated performance reason.
Chief Product Officer role eliminated effective immediately, as of January 13, 2025
Maxime Bouvat-Merlin remains employed as an advisor to the Interim CEO for a transition period
The filing does not state the length of the transition period or any compensation terms
Filing signed January 14, 2025 by Chief Legal and Strategy Officer Eddie Lazarus
Pediatrix Medical Group's board appointed Mark S. Ordan, a director and the company's Executive Chair, as chief executive officer effective January 12, 2025, succeeding Dr. James D. Swift. Dr. Swift's departure is treated as a termination without Cause, and Mr. Ordan's employment agreement sets a $1 million salary, a $2 million retention award and a 150% target bonus.
Mark S. Ordan appointed CEO effective January 12, 2025; Dr. James D. Swift steps down as CEO
Ordan's pay includes a $1 million salary, a $2 million one-time retention award and a target bonus of 150% of salary
Performance share award covers 640,000 shares, with vesting tied to stock price hurdles of 125%, 150% and 175% of the 20-day average close and a three-year anniversary
Ordan will remain Chair of the Board without additional board compensation
Vericel released preliminary, unaudited results for 2024, projecting total net revenue of about $237 million to $237.5 million, up 20%, and GAAP net income for the full year. It also issued 2025 guidance calling for 20% to 23% revenue growth and raised its mid-term gross margin and adjusted EBITDA margin targets. Shareholders should note that the company says the final audited figures may differ materially from these estimates.
Full-year 2024 total net revenue expected at about $237 million to $237.5 million, up 20%; full-year GAAP net income positive
Fourth-quarter 2024 revenue expected at $75.2 million to $75.7 million; GAAP net income expected at $17.5 million to $18.5 million
2025 guidance: 20% to 23% revenue growth, gross margin of 73% to 74%, adjusted EBITDA margin of 25% to 26%
About $167 million in cash, restricted cash and investments and no debt as of December 31, 2024; figures are preliminary and unaudited
Taylor Devices said its President, Alan R. Klembczyk, will retire effective June 1, 2025, and will not stand for reelection to the board at the 2025 annual meeting. Under a retirement agreement, he stays on as an employee through November 30, 2025, to provide support services, and keeps certain pay and stock option rights.
Alan R. Klembczyk retires as President effective June 1, 2025
He will not stand for reelection to the board at the 2025 annual meeting and remains a director until that term expires
Retirement Agreement dated January 14, 2025 keeps his base salary and death benefit through November 30, 2025, with eligibility for a 2025 bonus and stock option award
Brown-Forman's board approved a plan on January 13, 2025 to reduce its structural cost base and redirect resources toward growth, including cutting worldwide headcount by about 12% and closing its Louisville, Kentucky cooperage facility. The company expects $70 to $80 million in annualized cost savings and aggregate charges of $60 to $70 million, mostly cash, with most charges recognized in fiscal 2025, which affects shareholders through near-term costs and expected savings.
Plan approved by the Board on January 13, 2025 to reduce cost base and fund its Make It A Double growth ambition
Expected annualized cost savings of approximately $70 to $80 million; a portion will be reinvested in the business
Aggregate one-time charges of approximately $60 to $70 million, including $27 to $32 million for severance and benefits and $22 to $27 million for the cooperage closure
Headcount reduction of about 12%; plan substantially implemented in fiscal 2025 with the remainder by end of fiscal 2026
ACM Research said its 2024 revenue is now expected to be $755 million to $770 million, up from the $725 million to $745 million range it gave on November 7, 2024. It also projected 2025 revenue of $850 million to $950 million, citing trade policies, customer spending, supply chain limits and tool acceptance timing. The 2024 figures are preliminary and subject to audit.
2024 revenue outlook updated to $755 million to $770 million, versus $725 million to $745 million previously
Initial 2025 revenue outlook of $850 million to $950 million
Fourth quarter and full year 2024 results expected in late February 2025
CEO Dr. David Wang cited continued mainland China investment and new products, and said the impact of new U.S. component export restrictions on ACM Shanghai is manageable
United Rentals agreed on January 13, 2025, to buy H&E Equipment Services in an all-cash deal valued at a total enterprise value of about $4.8 billion, including about $1.4 billion of net debt. The deal will be done through a tender offer followed by a second-step merger, and the companies expect it to close in the first quarter of 2025. United Rentals has paused its share repurchase plan to reduce leverage after the deal, which the filing says the company expects to bring pro forma net leverage to about 2.3x at closing.
Purchase price is $92 per H&E share in cash, with a total enterprise value of about $4.8 billion.
H&E has a 35-day go-shop period ending 11:59 p.m. Eastern Time on February 17, 2025, during which it may seek alternative proposals.
United Rentals expects about $130 million of annualized cost synergies within 24 months of closing and about $120 million of annual revenue cross-sell synergies by year three.
The filing sets a termination fee of $127,047,785 payable by H&E in certain circumstances, and the company has paused its share repurchase plan.
Wabtec agreed on January 13, 2025 to acquire the Inspection Technologies division of Evident for $1.78 billion in cash, subject to customary adjustments. The division is expected to generate about $433 million in 2024 revenue and $112 million in EBITDA, and Wabtec expects to finance the deal with cash on hand, its credit revolver and an incremental term loan, with pro forma net leverage of about 2.5x.
Purchase price of $1.78 billion in cash, subject to customary adjustments; about 12.0x projected 2025 EBITDA as adjusted by Wabtec
Evident Inspection Technologies expected 2024 revenue of about $433 million, EBITDA of about $112 million (25.9% margin) and about 68% recurring revenue
Financing from cash on hand, credit revolver and incremental term loan; pro forma net leverage of about 2.5x at closing
Closing expected by the end of the first half of 2025, subject to regulatory approvals and customary conditions
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.